{"database": "lobbying", "table": "lobbying_activities", "rows": [[2790984, "53ee718c-546b-4ae8-b995-ffda6fbb1ec3", "Q1", "MEHLMAN CONSULTING, INC.", 284950, "WEDGEWOOD PHARMACY LLC", 2022, "first_quarter", "ANI", "Issues related to animal drug compounding.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2022-04-20T09:45:24-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2790984"], "units": {}, "query_ms": 0.6225099787116051, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}